Alinity m HR HPV Specimen Collection Study From Women Undergoing Routine Cervical Cancer Screening

Inclusion Criteria: Women is eligible if she meets the following: * Is 25 years of age or older * Is attending a participating clinic for routine cervical cancer screening following screening guidelines * Has an intact cervix * Is willing and able to provide documented informed consent * Is willing and able to undergo colposcopy, biopsy, and endocervical curettage (ECC) within 12 weeks (≤ 84 days) from the baseline visit, if required * Is willing and able to allow collection of two cervical cytology specimens Exclusion Criteria: A women is ineligible for the study if she meets any of the following criteria: * Is pregnant at the time of visit or plans to become pregnant within the following 12 weeks * Has any known medical condition that, in the opinion of the investigator, would result in increased risk of bleeding at biopsy * Has a known history of excisional or ablative therapy (e.g., LEEP, cone biopsy, cervical laser surgery, or cryotherapy) to the cervix in the last 12 months prior to the baseline visit * Had a cervical cytology specimen collected within the last 4 months * Is currently participating in any diagnostic trial for cervical cancer * Had a complete or partial hysterectomy, either supra cervical or involving removal of the cervix * Is currently participating or planning to participate in any clinical trial for HPV treatment (for the duration of this study) * Previous participation in this study